| Study Period | 2019 - 2030 |
| Market Size (2025) | USD 4.21 Billion |
| Market Size (2030) | USD 6.22 Billion |
| CAGR (2025 - 2030) | 8.13 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players*Disclaimer: Major Players sorted in no particular order |
Medical Linear Accelerator Market Analysis
The Medical Linear Accelerator Market size is estimated at USD 4.21 billion in 2025, and is expected to reach USD 6.22 billion by 2030, at a CAGR of 8.13% during the forecast period (2025-2030).
Medical linear accelerators are sophisticated radiation therapy devices used by healthcare providers to deliver highly targeted cancer treatments for cancer patients. Factors such as the increasing burden of cancer across the globe, coupled with growing advancements in linear accelerators and increasing demand from emerging markets, are expected to facilitate market expansion over the forecast period.
The increasing burden of cancer across the globe is expected to foster the uptake of external beam radiation therapy, which in turn is projected to accelerate demand for medical linear accelerators. For instance, according to the American Cancer Society, the estimated number of new cancer cases ramped up from 1.9 million in 2023 to 2.0 million in 2024. The most common type of cancers diagnosed in 2023 were breast, lung, and hematological malignancies.
Similarly, according to the estimates from the National Cancer Institute of Brazil, around 704 thousand new cancer cases are expected to be diagnosed between 2023 to 2025 except non-melanoma skin cancer. Thus, such an alarming burden of cancer is projected to accelerate the uptake of radiation therapies, which in turn is expected to fuel the adoption of medical linear accelerators over the study period.
Moreover, technological advancements in medical linear accelerators and several advantages associated with medical linear accelerators are projected to accelerate industry growth over the projection period. For instance, according to an article published by Frontiers in Oncology in January 2023, several advancements are being made in medical linear accelerators to manage organ motion and dose delivery in real time for better outcomes during radiation therapy. Thus, such advances are expected to promote the uptake of these accelerators, which in turn are projected to boost the market growth.
In addition, according to the above-mentioned source, the ongoing improvements in medical linear accelerators reduced toxicity and improved clinical applications with Intensity Modulated Radiation Therapy (IMRT), and Volumetric Modulated Arc Therapy (VMAT). Thus, such significant benefits associated with linear accelerators are projected to augment market growth over the projection period.
Furthermore, several strategic initiatives undertaken by market participants to foster their business avenues are another factor projected to fuel market growth. For instance, in July 2023, GE Healthcare collaborated with Elekta to expand access to precision radiation therapy solutions, including linear accelerators in India. Thus, such activities are poised to drive industry growth over the study period.
Thus, the above-mentioned such, as the alarming increase in the burden of cancers, technological advancements in products, and several strategic initiatives undertaken by industry participants are projected to boost market growth over the study period. However, the higher cost and slow adoption in developing economies is expected to hinder market growth over study period.
Medical Linear Accelerator Market Trends
Intensity Modulated Radiation Therapy Segment is Expected to Exhibit Significant Growth Over the Forecast Period
Intensity-modulated radiotherapy (IMRT) is an advanced radiation therapy technique that uses medical linear accelerators for the precise targeting and optimization of radiation doses to tumor sites to improve treatment outlook and reduce side effects.
Factors such as improved treatment outcomes with intensity-modulated radiotherapy (IMRT), growing demand for advanced radiation therapy, and the significant role of IMRT in managing several cancers are projected to accelerate industry growth over the forecast period.
The higher dose specificity and reduced risk of toxicity associated with intensity-modulated radiotherapy (IMRT) are expected to accelerate their adoption for cancer management. For instance, according to an article published by Radiation and Environmental Biophysics in December 2022, IMRT delivers a specified dose of radiation to a cancer target even in complex cases and has a lower risk of developing radiation-induced toxicity. Thus, the significance associated with IMRT is anticipated to bolster segment uptake over the forecast period.
Moreover, the long-term benefits of IMRT on cancer patients are further expected to fuel segment growth. For instance, according to September 2023 data from MD Anderson Cancer Center, the IMRT offers long-term benefits in treating patients with locally advanced non-small cell lung cancer (NSCLC) and has lower toxicity issues.
In addition, the crucial role of IMRT in cervical cancer is further projected to augment their adoption over the coming years. For instance, according to September 2022 data from MJH Life Sciences, IMRT is considered a standard therapy in women with cervical endometrial cancer. Thus, such advantages associated with IMRT are expected to foster its uptake in clinical settings over the study period.
Thus, the above-mentioned factors like improved treatment outcomes with intensity-modulated radiotherapy (IMRT), growing demand for advanced radiation therapy, and the significant role of IMRT in the management of several cancers are expected to fuel market growth over the study period.
Understand The Key Trends Shaping This Market
Download PDF
North America is Expected to Hold a Significant Share in the Market and is Expected to Witness High Growth Over the Study Period
North America is expected to witness robust growth opportunities in the medical linear accelerator market amid factors such as the growing burden of cancer in the region, increasing demand for radiation therapy, growing funding and grants, and several strategic initiatives undertaken by industry participants.
The alarming increase in the burden of cancer in the region is expected to accelerate demand for radiation therapy, which in turn is projected to foster the demand for medical linear accelerator systems. For instance, according to the Canadian Cancer Society, the number of cancer cases ramped from 239 thousand in 2023, and around 247 thousand people are expected to be diagnosed with cancer in Canada in 2024. Thus, the growing burden of cancer in the country is expected to boost market growth over the forecast period.
Moreover, the growing funding/grants to facilitate the development and launch of newer medical linear accelerators in the country are further anticipated to propel market growth over the projection period. For instance, in March 2024 the MJ Murdock Charitable Trust granted funding of USD 400 thousand to Jefferson Healthcare Foundation for the purchase of a linear accelerator (LINAC) cancer radiation treatment machine. Similarly, in March 2024 the Kahlert Foundation donated USD 2.5 million to the Carroll Hospital Foundation to purchase a new medical linear accelerator at its hospital. Thus, such activities are expected to promote the uptake of linear accelerators, which in turn likely to boost market growth over the study period.
Furthermore, several recent developments undertaken in the region are expected to augment industry growth in the region. For instance, in October 2023, Washington State University installed a new linear accelerator to provide advanced radiation therapy to the animals at the veterinary teaching hospital. Thus, such developments are projected to boost regional market growth over the study period.
Thus, the above mentioned factors such as, higher burden of cancer, growing funding activities, and several new installations of medical linear accelerators in the region is expected to accelerate regional market growth over study period.
Get Analysis on Important Geographic Markets
Download PDF
Medical Linear Accelerator Industry Overview
The medical linear accelerator market is semi-consolidated and consists of a few major players. The key players operating in the market are undertaking several initiatives such as new launches, collaboration, and funding activities to bolster their business avenues. Some of the key companies operating in the market are Elekta, Accuray Incorporated., Siemens Healthineers AG, ViewRay, Inc., BEVATECH GmbH, and Panacea Medical Technologies Pvt. Ltd. among others.
Medical Linear Accelerator Market Leaders
-
Accuray Inc.
-
Shinva Medical Instruments Co. Ltd.
-
Elekta
-
ViewRay, Inc.
-
Panacea Medical Technologies Pvt. Ltd.
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF
Medical Linear Accelerator Market News
- In May 2024, Elekta launched an AI-enabled, adaptive CT line linear accelerator (linac), Evo for image-guided radiation therapy treatments. This newly launched product is expected to transform the radiation therapy landscape.
- In April 2024, the Lady Hardinge Medical College (LHMC) introduced a radiation therapy facility for treating cancer patients in India.
Medical Linear Accelerator Industry Segmentation
As per the report's scope, a medical linear accelerator uses high-energy X-rays and takes the shape of a tumor to destroy it while leaving healthy cells. It is commonly used in external radiotherapy.
The Medical Linear Accelerator Market is Segmented by Product Type, Treatment Type, and Geography. The market is segmented as dedicated linear accelerator and non-dedicated linear accelerator based on product type. Based on treatment type the market is segmented into, intensity-modulated radiation therapy, volumetric modulated arc therapy, image-guided radiation therapy, and stereotactic radiosurgery/stereotactic body radiotherapy. The report also covers the market sizes and forecasts for the medical linear accelerator market in major countries across different regions. For each segment, the market size is provided in terms of value (USD).
| By Product Type | Dedicated Linear Accelerator | ||
| Non-Dedicated Linear Accelerator | |||
| By Treatment Type | Intensity Modulated Radiation Therapy | ||
| Volumetric Modulated Arc Therapy | |||
| Image Guided Radiation Therapy | |||
| Stereotactic Radiosurgery/Stereotactic Body Radiotherapy | |||
| Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| Australia | |||
| South Korea | |||
| Rest of Asia-Pacific | |||
| Middle East and Africa | GCC | ||
| South Africa | |||
| Rest of Middle East and Africa | |||
| South America | Brazil | ||
| Argentina | |||
| Rest of South America | |||
Need A Different Region or Segment?
Customize Now
Medical Linear Accelerator Market Research FAQs
How big is the Medical Linear Accelerator Market?
The Medical Linear Accelerator Market size is expected to reach USD 4.21 billion in 2025 and grow at a CAGR of 8.13% to reach USD 6.22 billion by 2030.
What is the current Medical Linear Accelerator Market size?
In 2025, the Medical Linear Accelerator Market size is expected to reach USD 4.21 billion.
Who are the key players in Medical Linear Accelerator Market?
Accuray Inc., Shinva Medical Instruments Co. Ltd., Elekta, ViewRay, Inc. and Panacea Medical Technologies Pvt. Ltd. are the major companies operating in the Medical Linear Accelerator Market.
Which is the fastest growing region in Medical Linear Accelerator Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Medical Linear Accelerator Market?
In 2025, the North America accounts for the largest market share in Medical Linear Accelerator Market.
What years does this Medical Linear Accelerator Market cover, and what was the market size in 2024?
In 2024, the Medical Linear Accelerator Market size was estimated at USD 3.87 billion. The report covers the Medical Linear Accelerator Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Medical Linear Accelerator Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Medical Linear Accelerators Industry Report
The global medical linear accelerator market is segmented by product type, including dedicated and non-dedicated linear accelerators, and by treatment type, encompassing intensity-modulated radiation therapy, volumetric modulated arc therapy, image-guided radiation therapy, and stereotactic radiosurgery/stereotactic body radiotherapy. The market analysis covers regions such as North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The industry report provides a comprehensive market overview and market forecast, offering insights into market growth and market trends.
The report includes detailed industry analysis and industry statistics, highlighting the market size and market value. It also discusses the market segmentation and market leaders, providing a thorough market review and market outlook. The industry research and industry reports compiled by Mordor Intelligence™ offer an in-depth look at the market data and market predictions, ensuring a robust understanding of the industry's growth rate and industry size.
Additionally, the report features a sample report PDF download, allowing access to a report example that includes industry information and industry research. This ensures that stakeholders are well-informed about market forecast and market growth. The report also emphasizes industry sales and market segmentation, providing a clear picture of the market's dynamics and market value.
